NEW YORK, April 25, 2017 /PRNewswire/ --
On Monday, benchmark US indices were in bullish colors as the NASDAQ Composite
On Monday, shares in New York headquartered WebMD Health Corp. recorded a trading volume of 393,687 shares. The stock ended the day 1.69% higher at $54.00. Shares of the Company, which provides health information services to consumers, physicians and other healthcare professionals, employers, and health plans through its Websites, mobile platforms, and health-focused publications in the US, are trading at a PE ratio of 28.78. WebMD Health's stock has gained 7.29% in the last one month and 8.96% in the previous three months. The Company's shares are trading above its 50-day and 200-day moving averages by 4.07% and 2.69%, respectively. Furthermore, WebMD Health's shares have a Relative Strength Index (RSI) of 65.15. Free research report on WBMD is available at:
Bowie, Maryland headquartered Inovalon Holdings Inc.'s stock finished Monday's session 1.72% higher at $11.85 with a total volume of 400,473 shares traded. Over the last one month and the previous three months, Inovalon Holdings' shares have advanced 1.72% and 4.41%, respectively. The Company's shares are trading below its 50-day and 200-day moving averages by 1.02% and 14.02%, respectively. Shares of Inovalon Holdings, which provides cloud-based platforms empowering a data-driven transformation from volume-based to value-based models throughout the healthcare industry, are trading at a PE ratio of 66.95. The stock has an RSI of 47.62. The complimentary research report on INOV can be downloaded at:
Watertown, Massachusetts headquartered athenahealth Inc.'s stock advanced 1.44%, to close the day at $118.91. The stock recorded a trading volume of 402,237 shares. athenahealth's shares have gained 9.86% in the last one month. The Company's shares are trading 4.00% and 2.00% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, are trading at a PE ratio of 227.80. Additionally, the stock has an RSI of 63.03. Visit us today and access our complete research report on ATHN at:
On Monday, shares in Atlanta, Georgia headquartered Cotiviti Holdings Inc. ended the session 0.05% higher at $41.74 with a total volume of 119,388 shares traded. Cotiviti Holdings' shares have gained 6.45% in the last one month and 25.23% in the previous three months. Shares of the Company, which develops and sells analytics-driven payment accuracy solutions primarily for the healthcare sector, are trading at a PE ratio of 76.59. The stock is trading 6.87% above its 50-day moving average and 25.34% above its 200-day moving average. Moreover, the Company's shares have an RSI of 57.53.
On April 13th, 2017, research firm Jefferies initiated a 'Hold' rating on the Company's stock, with a target price of $45 per share. Get free access to your research report on COTV at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: +44-330-808-3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All